Elantas Beck India Limited
₹14,104.00▲ +312.00 (+2.26%)
ELANTAS·NSE·Chemicals
Market Cap
11133.12 Cr
PE Ratio
75.66
Volume
964
Day High - Low
14104.00 - 13802.00
52W High-Low
15150.00 - 8900.00
₹14,104.00▲ +312.00 (+2.26%)
Market Cap11133.12 Cr
PE Ratio75.66
Volume964
Day High - Low14104.00 - 13802.00
52W High-Low15150.00 - 8900.00
Elantas Beck India Limited (ELANTAS): company summary
The company's annual revenue rose 13.2% to ₹848 crore, while annual net profit increased 5.7% to ₹148 crore.
Elantas Beck India Limited (ELANTAS) is a small-cap Chemicals company valued at ₹11,133 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Elantas Beck India Limited last traded at ₹14,104, up 2.26% on the day.
- Recent developments
- 2026-09-27: Elantas Beck India reported Q1FY27 results with net profit reaching ₹708.62 crore. 2026-08-05: The company was among the gainers in the 'B' group. 2026-08-04: The company's Q1 results showed a 80% year-over-year increase in net profit.
- Financial performance
- The company's annual revenue rose 13.2% to ₹848 crore, while annual net profit increased 5.7% to ₹148 crore. The latest quarter saw revenue jump 34.8% to ₹283 crore and net profit surge 82.1% to ₹71 crore, showing strong growth in recent months despite a slight decline in net profit margin to 17.5% from 18.7%.
- Valuation multiples
- The stock trades at 75.7 times earnings, 7.97 times book value. It yields 0.1%.
- Things to watch
- The stock is 11.1% below its 52-week high. The net profit margin declined 1.2 percentage points to 17.5%. The company's market cap is ₹10,698 crore, placing it in the small-cap category.
- Where it stands
- Elantas Beck India's latest quarter results show strong growth with net profit up 82.1% year-over-year. The company's annual net profit rose 5.7% to ₹148 crore, while revenue increased 13.2% to ₹848 crore. The stock is currently 11.1% below its 52-week high.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
15.70%
Strong
P/E
75.66x
Expensive
Debt / Equity
0.00
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed
Price performance
Day₹13802
₹14104
52W₹8900
₹15150
DocStoX take
Supported by momentum (7.5) and risk (7.2), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Low confidence5.3
/10
Weak
Quality
Solid
ROE 15.7%
Valuation
Expensive
P/E 75.7×
Growth
No data
No multi-year history
Risk
Moderate
D/E 0.00
Momentum
Strong
83% of 52-week range
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹11,133 Cr
52W High / Low
₹15150 / ₹8900
Dividend Yield
0.06%
Promoter Holding
75.00%
EPS (TTM)
₹186.41
Book Value
₹1272.00
Key highlights
- Low leverage — D/E 0.00
- Profitable in all of the last 4 years
- Capital works hard — ROCE 21%
- Valuation is weak (0.0/10)
- Expensive at 76× earnings
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Elantas Beck India Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Elantas Beck India Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Elantas Beck India Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing